Amedeo Smart

Free Medical Literature Service

 

Amedeo

Prostate Cancer
  Free Subscription

Articles published in
J Natl Cancer Inst
    February 2026
  1. FISCHER MP, Alena M, Braun A, Kraft J, et al
    Polygenic risk scores for pre-MRI risk stratification in men with clinically suspected prostate cancer.
    J Natl Cancer Inst. 2026 Feb 2:djag027. doi: 10.1093.
    >> Share

    January 2026
  2. DA SILVA M, Fritz J, Elhakeem A, Jochems SHJ, et al
    Weight trajectories throughout adulthood and prostate cancer incidence, aggressiveness, and death in 258,494 men.
    J Natl Cancer Inst. 2026 Jan 23:djag014. doi: 10.1093.
    >> Share

  3. WESTVOLD SJ, Long JB, Fan J, Kc M, et al
    Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer.
    J Natl Cancer Inst. 2026;118:130-140.
    >> Share

  4. SCUDERI S, Tin AL, Marra G, Bianchi L, et al
    Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.
    J Natl Cancer Inst. 2026;118:76-84.
    >> Share

    December 2025
  5. SPAUR M, Koutros S, Hurwitz LM, Manley CK, et al
    Drinking water nitrate, disinfection byproducts, and prostate cancer incidence in the Agricultural Health Study.
    J Natl Cancer Inst. 2025 Dec 5:djaf350. doi: 10.1093.
    >> Share

  6. SCHENK JM, Gulati R, Beatty SJ, Plymate S, et al
    Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Cancer Active Lifestyle Study.
    J Natl Cancer Inst. 2025;117:2682-2686.
    >> Share

    November 2025
  7. DE FERIA CARDET RE, Goodall S, Laba TL, Haas M, et al
    What matters to society when making decisions about reimbursing drugs for prostate cancer: a discrete choice experiment.
    J Natl Cancer Inst. 2025 Nov 3:djaf315. doi: 10.1093.
    >> Share

  8. VO JB, Brown DW, Buller ID, Shing JZ, et al
    Associations of self-identified race and ethnicity and genetic ancestry with mortality among cancer survivors.
    J Natl Cancer Inst. 2025;117:2382-2387.
    >> Share

    September 2025
  9. VERTOSICK EA, Vickers A, Dahlin A, Ulmert D, et al
    Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer.
    J Natl Cancer Inst. 2025 Sep 19:djaf271. doi: 10.1093.
    >> Share

    August 2025
  10. QIAN Z, Korn S, Zurl H, Stelzl D, et al
    Active surveillance for low-risk prostate cancer: long-term utilization and outcomes among black men.
    J Natl Cancer Inst. 2025 Aug 14:djaf224. doi: 10.1093.
    >> Share

  11. MAKAROV DV, Thomas JK, Ciprut S, Rivera AJ, et al
    Prostate Cancer Imaging Stewardship: a multi-modal, physician-centered intervention for guideline-concordant imaging.
    J Natl Cancer Inst. 2025 Aug 11:djaf210. doi: 10.1093.
    >> Share

    June 2025

  12. Correction to: The association of where patients with prostate cancer live and receive care on racial treatment inequities.
    J Natl Cancer Inst. 2025 Jun 26:djaf148. doi: 10.1093.
    >> Share


  13. Correction to: The association of where patients with prostate cancer live and receive care on racial treatment inequities.
    J Natl Cancer Inst. 2025 Jun 13:djaf142. doi: 10.1093.
    >> Share

  14. SCILIPOTI P, Garmo H, Gedeborg R, Robinson D, et al
    Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study.
    J Natl Cancer Inst. 2025;117:1142-1150.
    >> Share

    May 2025
  15. CHEN F, Paik A, Sheng X, Cheng I, et al
    Risk of aggressive prostate cancer with successive generations in the U.S. among Latino men.
    J Natl Cancer Inst. 2025 May 27:djaf119. doi: 10.1093.
    >> Share

  16. PATRICK SM, Ombuki WM, Ndambuki J, Oyaro MO, et al
    Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decade.
    J Natl Cancer Inst. 2025 May 9:djaf117. doi: 10.1093.
    >> Share

  17. MCWILLIAM A, Marshall D, Kerns SL, Barnett GC, et al
    Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis.
    J Natl Cancer Inst. 2025;117:1018-1026.
    >> Share

    February 2025
  18. SEKAR RR, Zebib L, Stensland KD, Herrel LA, et al
    Structural inequities in the availability of prostate cancer clinical trial opportunities.
    J Natl Cancer Inst. 2025 Feb 26:djaf047. doi: 10.1093.
    >> Share

    January 2025
  19. TOSOIAN JJ
    Active surveillance for prostate cancer: How active is too active?
    J Natl Cancer Inst. 2025 Jan 27:djae342. doi: 10.1093.
    >> Share

  20. MEZGER NCS, Seraphin TP, Balle R, Griesel M, et al
    NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers.
    J Natl Cancer Inst. 2025;117:120-133.
    >> Share

  21. GOGLIA AG, Alshalalfa M, Khan A, Isakov DR, et al
    Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers.
    J Natl Cancer Inst. 2025;117:188-197.
    >> Share

    November 2024
  22. HAMMARLUND N, Holt SK, Etzioni R, Morehead D, et al
    The Association of Where Patients with Prostate Cancer Live and Receive Care on Racial Treatment Inequities.
    J Natl Cancer Inst. 2024 Nov 20:djae302. doi: 10.1093.
    >> Share

  23. ZHAO Y, Gulati R, Yang Z, Newcomb L, et al
    Projected Outcomes of Reduced-Biopsy Management of Grade Group 1 Prostate Cancer: Implications for Relabeling.
    J Natl Cancer Inst. 2024 Nov 20:djae296. doi: 10.1093.
    >> Share

    October 2024
  24. COOPERBERG MR, Braun AE, Berlin A, Kibel AS, et al
    When is prostate cancer really cancer?
    J Natl Cancer Inst. 2024 Oct 1:djae200. doi: 10.1093.
    >> Share

  25. KATKI HA, Prorok PC, Castle PE, Minasian LM, et al
    Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    J Natl Cancer Inst. 2024;116:1675-1682.
    >> Share

  26. LIU S, Rivero SL, Zhang B, Shen K, et al
    BATF-dependent Th17 cells act through the IL-23R pathway to promote prostate adenocarcinoma initiation and progression.
    J Natl Cancer Inst. 2024;116:1598-1611.
    >> Share

    September 2024
  27. EL KHOURY CJ, Freedland SJ, Gandhi K, Keith SW, et al
    Disparities in the Utilization of MRI for Prostate Cancer Detection: A Population-Based Study.
    J Natl Cancer Inst. 2024 Sep 23:djae234. doi: 10.1093.
    >> Share

    August 2024
  28. KATKI HA, Prorok PC, Castle PE, Minasian LM, et al
    Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    J Natl Cancer Inst. 2024;116:1280-1287.
    >> Share

    July 2024
  29. FARAJ KS, Oerline M, Kaufman SR, Dall C, et al
    Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitors.
    J Natl Cancer Inst. 2024 Jul 25:djae155. doi: 10.1093.
    >> Share

    June 2024
  30. DING CC, Tony Su Z, Erak E, DePaula Oliveira L, et al
    Predicting prostate cancer grade reclassification on active surveillance using a deep Learning-Based grading algorithm.
    J Natl Cancer Inst. 2024 Jun 18:djae139. doi: 10.1093.
    >> Share

    May 2024
  31. BJORNEBO L, Razdan S, Discacciati A, Palsdottir T, et al
    Prostate Cancer Incidence and Mortality in Men Exposed to alpha1-Adrenoceptor Antagonists.
    J Natl Cancer Inst. 2024 May 8:djae108. doi: 10.1093.
    >> Share

    February 2024
  32. BASU A, Rais-Bahrami S
    Genomic risk scores in prostate cancer: polygenic yes, but are they poly-ancestral?
    J Natl Cancer Inst. 2024 Feb 16:djae025. doi: 10.1093.
    >> Share

  33. LAO Y, Guan X, Wang J, Bai Y, et al
    RE: Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study.
    J Natl Cancer Inst. 2024 Feb 12:djae032. doi: 10.1093.
    >> Share

    January 2024
  34. LEE KM, Nelson T, Bryant A, Teerlink C, et al
    Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry.
    J Natl Cancer Inst. 2024 Jan 11:djae002. doi: 10.1093.
    >> Share

  35. WILKINSON S, Sowalsky AG
    Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy.
    J Natl Cancer Inst. 2024;116:12-14.
    >> Share

  36. FEDELI U, Barbiellini Amidei C, Han X, Jemal A, et al
    Changes in cancer-related mortality during the COVID-19 pandemic in the United States.
    J Natl Cancer Inst. 2024;116:167-169.
    >> Share

    December 2023
  37. CRUMP C, Stattin P, Brooks JD, Sundquist J, et al
    Risks of Depression, Anxiety, and Suicide in Partners of Men with Prostate Cancer: A National Cohort Study.
    J Natl Cancer Inst. 2023 Dec 7:djad257. doi: 10.1093.
    >> Share

    November 2023
  38. FREEMAN JR, Saint-Maurice PF, Watts EL, Moore SC, et al
    Actigraphy-derived measures of sleep and risk of prostate cancer in the UK Biobank.
    J Natl Cancer Inst. 2023 Nov 28:djad210. doi: 10.1093.
    >> Share

  39. COOPERBERG MR
    Can early prostate cancer screening help address mortality disparities among Black men?
    J Natl Cancer Inst. 2023 Nov 10:djad217. doi: 10.1093.
    >> Share

    October 2023
  40. HU S, Chang CP, Snyder J, Deshmukh V, et al
    Mental health outcomes in a population-based cohort of patients with prostate cancer.
    J Natl Cancer Inst. 2023 Oct 23:djad175. doi: 10.1093.
    >> Share

  41. MA T, Jin L, Bai S, Liu Z, et al
    Loss of Feedback Regulation between FAM3B and Androgen Receptor Driving Prostate Cancer Progression.
    J Natl Cancer Inst. 2023 Oct 17:djad215. doi: 10.1093.
    >> Share

    September 2023
  42. KENSLER KH, Johnson R, Morley F, Albrair M, et al
    Prostate Cancer Screening in African American Men: A Review of the Evidence.
    J Natl Cancer Inst. 2023 Sep 15:djad193. doi: 10.1093.
    >> Share

  43. SUMIYOSHI T, Wang X, Warner EW, Sboner A, et al
    Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial.
    J Natl Cancer Inst. 2023 Sep 7:djad184. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016